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Recent evidence supports the presence of an
L-glutamyl methyltransferase(s) in eukaryotic cells,
but this enzyme class has been defined only in
certain prokaryotic species. Here, we characterize
the human C6orf211 gene product as ‘‘acidic residue
methyltransferase-1’’ (Armt1), an enzyme that specif-
ically targets proliferating cell nuclear antigen (PCNA)
in breast cancer cells, predominately methylating
glutamate side chains. Armt1 homologs share struc-
tural similarities with the SAM-dependent methyl-
transferases, and negative regulation of activity by
automethylation indicates a means for cellular con-
trol. Notably, shRNA-based knockdown of Armt1
expression in two breast cancer cell lines altered
survival in response to genotoxic stress. Increased
sensitivity toUV, adriamycin, andMMSwasobserved
in SK-Br-3 cells, while in contrast, increased resis-
tance to these agents was observed in MCF7 cells.
Together, these results lay the foundation for defining
the mechanism by which this post-translational
modification operates in the DNA damage response
(DDR).
INTRODUCTION
Protein methyltransferases regulate important biological func-
tions in eukaryotic cells through the post-translational modifica-
tion (PTM) of a wide array of targets including, but not limited to,
DNA damage response (DDR) mediators, DNA repair proteins,
and transcription factors (Grillo and Colombatto, 2005). The ma-
jority of these enzymes catalyze transfer of methyl groups from
the cofactor s-adenosyl methionine (SAM) to amine containing
side chains of arginine or lysine generating a methylated residue1288 Cell Reports 10, 1288–1296, March 3, 2015 ª2015 The Authorsand the by-product s-adenosyl homocysteine (SAH). SAM-
dependent methyltransferases (SAM-MTs) that methylate
carboxylic acid groups also have been described in eukaryotic
cells, and they too serve important biological roles.
Four classes of protein carboxyl methyltransferases (cSAM-
MTs) have been described (Xie and Clarke, 1993). The pro-
tein iso-aspartate methyltransferases (PIMTs) are widespread
throughout prokaryotes and eukaryotes, and these enzymes
repair damaged or aging proteins. The substrates of PIMT are
carboxyl groups of L-iso-aspartate or D-aspartate residues,
which occur spontaneously in aging proteins. Two additional
classes of cSAM-MTs are leucine carboxyl methyltransferase
(LCMT) and isoprenylcysteine O-methyltransferase (ICMT).
These enzymes are exclusive to eukaryotes, and their substrates
are the carboxyl-terminal leucine in protein phosphatase 2A (Sta-
nevich et al., 2011) and the carboxyl-terminal isoprenylated
cysteine of membrane-associated proteins (Yang et al., 2011),
respectively. The substrate of a fourth class of protein cSAM-
MT is the carboxyl groupof L-glutamate residues, but description
of this type of enzyme has been limited to prokaryotic cells.
Previously, we examined the post-translational state of a can-
cer-associated isoform of the DNA replication and repair factor
proliferating cell nuclear antigen (PCNA) using liquid chromatog-
raphy coupled to tandemmass spectrometry (LC-MS/MS) (Hoelz
et al., 2006). By scrutinizing the MS/MS spectra from this iso-
form, we identified carboxyl methylation (methyl esters) on
several glutamate and some aspartate residues. Since our
observations, glutamyl methylation has been observed on the
HIV-resistance protein X-DING-CD4 (Lesner et al., 2009), and
aspartate andglutamatemethylationhasbeen identified andvali-
dated on 2% of the HeLa cell proteome (Sprung et al., 2008).
These findings provided compelling evidence for the existence
of cSAM-MTs that target acidic residues in eukaryotic proteins
and that methylation of acidic residues in PCNA may represent
an unrecognized level of protein regulation in human cells.
Functionally, PCNA is essential protein and member of the
DNA sliding clamp family of proteins (for reviews, see Moldovan
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Figure 1. A Carboxyl Methyltransferase
Targets PCNA in Human Cells
(A) MDA-MB-468 breast cancer cell extracts
possess SAM-dependent carboxyl methyltransfer-
ase activities. Mean counts from vapor diffusion
assays are presented ± SD and compared using
Student’s t test.
(B) PCNA (2, 5, or 10 mg) or BSA were added to
breast cancer cell extracts and mean counts from
vapor diffusion assay presented ± SD and results
compared using Student’s t test.
(C) PCNA-dependent methyltransferase activity
was enriched and resolved by 2D PAGE. The po-
sition of the C6orf211 gene product in the gel is
noted with an arrow.
(D) Proteins identified by LC-MS/MS in activity
enriched fractions classified by cellular functions.
See also Figure S1.et al., 2007 and Stoimenov and Helleday, 2009). By tethering
elements to the DNA, PCNA is required for DNA replication
and DNA repair. A large and seemingly endless number of pro-
tein interactions have been observed with PCNA, which lends
additional support for its function in cell cycle progression, chro-
matin maintenance, and programmed cell death. Interactions
with PCNA therefore must be highly coordinated, and the PTM
of PCNA is needed to control its functions within the cell. Ubiq-
uitination and SUMOylation of PCNA have proven fundamental
to regulation of DNA damage tolerance (DDT) pathways (Hoege
et al., 2002; Stelter and Ulrich, 2003). Monoubiquitination of
PCNA in response to DNA damage anchors its interactions
with the translesion (TLS) DNA polymerases in the error-prone
branch of DDT. Interestingly, five eukaryotic TLS polymerases
have been described that are capable of polymerizing (poten-
tially incorrect) nucleotides on damaged template DNA, and
the function of each polymerase appears specific to the type(s)
of DNA damage encountered (Waters et al., 2009). The error-
free branch of DDT requires K63-linked polyubiquitination and
SUMOylation of PCNA, which supports a poorly understood
template switching mechanism to bypass damage to template
DNA. Phosphorylation of PCNA by the EGF receptor has
also been described in breast cancer cells (Wang et al., 2006).Cell Reports 10, 1288–129Tyrosine phosphorylation of PCNA regu-
lates K43-linked polyubiquitination of
PCNA, which stabilizes chromatin bound
PCNA by preventing its proteosomal
degradation.
Here, we report that a human gene
(C6orf211) product is a first-in-class eu-
karyotic cSAM-MT that is capable of
methylating PCNA. This protein, which
we have termed ‘‘acidic residue methyl-
transferase-1’’ (Armt1), shows significant
structural similarities to class I SAM-MTs
(Schubert et al., 2003), and its activity ap-
pears to be tightly regulated in human
cells. Knockdown of Armt1 expression al-
ters DNA damage survival rates in breastcancer cells linking its function to the DDR. Opposing survival
phenotypes support a complex role for Armt1 in the DDR and
indicate a dependence on a factor(s) that is differentially ex-
pressed between these two cell types. In addition to uncovering
another level of protein regulation in eukaryotic cells, our identi-
fication of Armt1 uncovers a potentially powerful target to selec-
tively kill cancer cells.
RESULTS
PCNA Is the Substrate of a Carboxyl Methyltransferase
in Human Cells
Our previous identification of methylation on several acid
residues in PCNA was surprising because a eukaryotic methyl-
transferase capable of catalyzing this reaction was unknown.
To determine whether carboxyl methylation was an enzymatic
phenomenon, we investigated breast cancer cell extracts for
carboxyl methyltransferase activity (Figure 1A). Using a vapor
diffusion assay, we were not only able to detect SAM-MT activ-
ity, but were also able to distinguish cSAM-MT activity (Murray
and Clarke, 1984). After assaying extracts with 3H-methyl-
labeled SAM, the reactions were equilibrated with base and
spotted onto filter paper placed in the neck of a scintillation6, March 3, 2015 ª2015 The Authors 1289
H. sapiens LDNSGFELVTDLILADFLLSSELATEVHFYGKTIPWFVSDTTIHDFNWLIE 
M. musculus LDNSGFELITDLVLADFLFSSELATEIHFHGKSIPWFVSDVTEHDFNWIVE
G. gallus LDNAGFELVSDLVLTDFLLSSKLADEVHFHGKSIPWYVSDTTKNDFNWTIK
X. laevis LDNAGFELITDFVLADALLSFRLASEVHFHGKCMPWFVSDTTKHDFNWTIK
D. rerio LDNAGFELVTDLVLADFLISSGLAKQIRFHGKSIPWFVSDVTKQDFEWTIK
C. elegans LDNSGVELTGDLIVAEFFISRGFADKVVIHGKAIPWFVSDVTKPDLDWTIE
S. cerevisiae LDNSGFELYADLMLAAFLLQSGLATKCIFHAKDIPYMVSDVMLKDFDILVH
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Figure 2. The C6orf211 Protein Possesses a SAM-Dependent Methyltransferase Fold
(A) I-Tasser predicted secondary structure suggests a SAM-MT fold.
(B) Alignment of C6orf211 homologs identified conservation in predicted SAM binding site.
(C) Two 180 views of a threadedmodel of C6orf211 based on PDB 3PT1 structure, central b sheets and a helices of the SAM-MT core fold are labeled. Conserved
active site glutamate 258 and aspartate 291 are highlighted as yellow sticks. Structural images were produced using PyMOL (http://www.pymol.org).
See also Figures S1 and S2.vial. Hydrolysis of carboxyl methylation then generates volatile
methanol, which evaporates from the extracts and diffuses into
scintillation fluid. The amount of radioactivity in the fluid is there-
fore proportional to cSAM-MT activity of the extracts. A small but
significant amount of activity was observed when breast cancer
cell extracts were assayed by vapor diffusion (Figure 1A). This
activity was specific to the extracts and sensitive to heat dena-
turation, indicating the presence of cSAM-MT enzymes and
substrates in the extracts. To investigate whether PCNA was a
substrate for a cSAM-MT in breast cancer cells, we added
increasing amounts of exogenous PCNA to the assays and
examined its impact on activity (Figure 1B). As a result of
PCNA addition, a large and dose-dependent increase in
cSAM-MT activity was observed. When equivalent amounts of
a nonspecific protein, BSA, were added to the assays, an in-
crease in cSAM-MT activity was not observed. These data indi-
cated that a cSAM-MT was present in human cell extracts and
was capable of modifying acidic residues in PCNA.
C6orf211 Encodes a DUF 89 Protein Containing a
Conserved SAM-MT Structural Fold
To identify the cSAM-MT responsible for modifying PCNA,
we fractionated cell extracts and enriched for enzyme activity.
Following protein precipitation with 30% ammonium sulfate, ac-
tivity was further enriched by phenyl Sepharose chromatography.1290 Cell Reports 10, 1288–1296, March 3, 2015 ª2015 The AuthorsActive fractions were then separated by gel filtration chromatog-
raphy prior to other chromatographic steps. However, additional
chromatographic attempts yielded no activity. This apparent
loss of activity at steps of higher enrichment prevented us from
isolating the enzyme to near homogeneity, so we closely exam-
ined enriched fractions displaying PCNA-directed cSAM-MT
activity for the presence of a potential cSAM-MT. Individual poly-
peptides present in the active gel filtration fractions were sepa-
rated by 2D PAGE, and the polypeptides present in the gel were
subsequently excised, proteolytically digested, and identified
by LC-MS/MS (Figures 1C and 1D). Previously identified methyl-
transferaseswerenot observed in theactive fractions, so the iden-
tified proteins were classified according to their cellular function
(Figure 1D). Aiding identification of the methyltransferase in ques-
tion is that, in general and despite having high sequence diver-
gence, SAM-MTs contain an evolutionarily conserved Rossman-
like structural fold. The Rossman-like SAM-MT fold is composed
of a core ‘‘a-b-a’’ sandwich of six parallel b strands and a
C-terminal antiparallel b strand, flanked by five a helices, in addi-
tion to a variable N-terminal cap region (Martin and McMillan,
2002). Blast-based sequence alignments, together with second-
ary structure prediction and fold recognition using the I-TASSER
server (Zhang, 2008), revealed that one isolate in the 2D PAGE
gel (Figure 1C), the product of an uncharacterized human gene
C6orf211, likely contained a SAM-MT fold (Figure 2A).
C6orf211    224DMEHLWSLLSNCKKTREKASATRVYIVLDNSGFELVTDLILADFLLSSELA----TEVHFYGKTIPWFVSDTTIHDFNWLIEQVKHS-------------------NHKWMSKCGADWEEYIK
CheR 1bc5   101HFPILAEHARRRH------GEYRVWSAAASTGEE---PYSIAITLADALGMAPGRWKVFASDID-----TEVLEKARSGI---YRLSELKTLSPQQLQRYFMRGTGPHEGLVRV---RQELA-
C6orf211 ss LHHHHHHHHHHHHHLLLLLLLLEEEELLLLLLHHHHHHHHHHHHHHHLLLL----LEEEEEELLLLLLLLLLLHHHHHHHHHHHHLL-------------------LLHHHHHHHHHHHHHHH
CheR ss        HHHHHHHHHHLLL------LLEEEEELLLLLLLL---HHHHHHHHHHHHLLLLLLEEEEEEELL-----HHHHHHHHHLE---EEHHHLLLLLHHHHHHHEEEELHHHLLEEEE---LHHHH-
C6orf211    325MGKWVYHNHIFWTLPHEYCAMPQVAPDLYAELQKAHLILFKGDLNYRKLTGDRKWEFSVPFHQALNGFHPAP-----LCTIRTLKAEIQVGLQPGQGEQLLASEPSWWTTGKYGIFQYDG-PL
CheR 1bc5   204-NYVEFSSV--NLLE-----------KQYNVPGPFDAIFCRN--VMIY--FDKT-----TQEDILRRF-VPLLKPDGLLFAGHSENFSN----------------LVREFSLRGQTVYALS--
C6orf211 ss    LLLLEEEELLHHHLLLLHHHLLLLLLHHHHHHHLLLEEELLLHHHHHHHHLLLLLLLLLLLLLLLLLLLLLL-----LLLLLLLLLLLLLLLLLLHHHHHLLLLLHHHHHLLLEEELLLL-LL
CheR ss -LLEEEEEL--LLLL-----------LLLLLLLLEEEEEELL--LHHH--LLHH-----HHHHHHHHH-HHHEEEEEEEEELLLLLLLL----------------LLLLLEELLLLEEELL--
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Figure 3. Structural Similarities of the C6orf211 Pocket with the SAM Binding Pocket of CheR
(A) Structural superimpositions of S. cerevisiae protein YMR027W (PDB: 3PT1) in cyan and S. typhimurium CheR (Uniprot code: P07801, PDB code: 1BC5) in
green, revealing two acidic residues (E129 and D154 in CheR) in both proteins in similar positions within the active site.
(B) Structure-based sequence alignment of human C6orf211 with S. typhimurium CheR. Conserved residues are highlighted in red. Stars indicate active site
acidic residues. Motifs I and II are highlighted with blue boxes. The first active site glutamate is conserved, the second, structurally equivalent acid residue occurs
after a loop insert in C6orf211. I-Tasser predicted the secondary structure shown for C6orf211 together with 1BC5.pdb secondary structure as defined by DSSP.
Green H indicates helix. Blue E indicates strand, and L is loop/coil. The conserved secondary structure elements in common with the core SAM-MT fold and the
CheR insert are labeled.
See also Figure S3.C6orf211 belongs to the domain of unknown function (DUF)
89 family of uncharacterized proteins, present in both eukaryota
and archaea. Structure-based sequence alignments of C6orf211
with the four DUF89 protein homologs, as previously determined
by structural genomics efforts, revealed a predicted conserva-
tion of secondary structures (Figure S1). Of these homologs,
the closest structural neighbor to human C6orf211 was the bio-
chemically uncharacterized DUF89 protein from budding yeast,
YMR027W (Protein Data Bank [PDB] code: 3PT1), which shared
29% sequence identity. This suggested that the DUF89 family of
proteins likely represents a subset of the SAM-MT domain, as
the seven-stranded central b sheet of the DUF89 structure differs
slightly from the classical SAM-MT fold by having a b strand
occurring before b1, which we term bZ, and the loss of b strand
6 (Figures 2A, 2C, and S1). The noted sequence divergence
of SAM-MT family proteins extends to their active sites, but
the occurrence of two SAM-binding motifs is generally well
conserved. Motif I is present in the loop regions connecting the
first b strand (b1) and second a-helix (aA), while motif II is located
in the loop connecting the second b strand (b2) and third a-helix
(aB). Together, motifs I and II help form the SAM binding pocket.
Sequence alignments of several eukaryotic C6orf211 proteins
revealed that motifs I and II sequences are well conserved and
thus are likely essential for protein function (Figure 2B). Notably,Ceone of the closest homologs to the DUF89 family with known
structure and catalytic activity is the bacterial glutamyl cMTase
CheR. Despite showing limited sequence conservation to other
SAM-MTs in its motif I and motif II sequences, the SAM binding
pocket of CheR possesses conserved acidic residues that are
responsible for hydrogen bonding with SAH (Djordjevic and
Stock, 1997). These acidic residues are conserved in DUF89
proteins, including yeast YMR027W, and in human C6orf211
are residues Glu258 and Asp291 (Figures 2 and S2). Sequence
alignments and structural superimpositions reveal that the first
acidic active site residue is conserved between S. cerevisiae
YMR027W (3PT1.pdb) and S. typhimurium CheR (1BC5.pdb)
(Figure 3). A second acidic residue is in a structurally equivalent
position, but it occurs at the end of a loop insert after b strand 2 in
the DUF89 sequences that includes C6orf211. The equivalent
residue in CheR occurs at the end of b strand 2. Human
C6orf211 additionally shares homology to the human methyl-
transferase 10 domain containing protein (Figure S3A), although
SAM binding in the active site of this latter protein does not
require the well-conserved acidic residues. Sequence analyses
also suggested a second C6orf211-like DUF89 domain in the hu-
man genome, occurring in the C terminus of pantothenate kinase
4 (PNK4; Figure S3B). The N-terminal kinase domain of PNK4
lacks an essential catalytic residue, and thus, the C-terminalll Reports 10, 1288–1296, March 3, 2015 ª2015 The Authors 1291
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Figure 4. C6orf211 Codes for Armt1, a Carboxyl Methyltransferase Capable of Modifying PCNA
(A) Recombinant His-tagged C6orf211 was expressed in insect cells, isolated by Ni2+ Sepharose chromatography prior to 10% SDS-PAGE and colloidal
Coomassie blue staining.
(B) C6orf211 (0.2 mg) was assayed by vapor diffusion in absence and presence of PCNA (2 mg). Mean background (PCNA alone) subtracted counts are presented
± SD and comparisons made using Student’s t test.
(C) Self methylation restricts activity; 2 mg of untreated C6orf211 or C6orf211 pretreated at 37C for 90 min in the presence of 10 mM sinefungin were assayed for
methyltransferase activity. Mean background (PCNA alone) subtracted absorbances from three replicate assays are presented.
(D) PCNA is a target of C6orf211 methyltransferase activity. Mean background (PCNA alone) subtracted activities from three independent assays in the absence
and presence of increasing amounts of PCNA are presented.
(E) Pre-steady-state kinetics support an inhibitory role for Armt1 self-methylation.C6orf211-like/DUF89 domain could instead be key to its poorly
defined cellular function. As far as we are aware, this is the first
prediction of structural and functional commonalties between
C6orf211, the DUF89 protein family and methyltransferases
that include the bacterial glutamyl cSAM-MT CheR.
The Product of C6orf211, Armt1, Carboxyl Methylates
PCNA
The identification of C6orf211 in protein fractions enriched for
PCNA-dependent cSAM-MT activity and its structural similar-
ities to the bacterial cSAM-MT CheR was intriguing because it
supported a novel protein cSAM-MT function for this uncharac-
terized gene product. To establish the human C6orf211 gene as
encoding a cSAM-MT, we expressed, purified, and examined
the recombinant protein for cSAM-MT activity directed toward
PCNA (Figure 4). Using the vapor diffusion assay, we were able
to detect cSAM-MT activity in the presence of purified recombi-
nant PCNA (Figure 4B). This confirmed that the C6orf211 gene
product was a cSAM-MT, and we designated it Armt1. In addi-
tion to the activity observed in the presence of PCNA, significant
activity alsowas observed in the absence of PCNA. Although this
was a surprising result, it did support an automethylation func-1292 Cell Reports 10, 1288–1296, March 3, 2015 ª2015 The Authorstion for Armt1, and it was possible that Armt1 was regulating
its activity perhaps by modifying key active site acidic residues
(Figure 2). Negative regulation of Armt1 activity by self-methyl-
ation was congruent with observations made during initial isola-
tion of the enzyme (Figure 1). In this instance, purification of
Armt1 would support automethylation, and this could explain
the apparent loss of activity observed with more highly enriched
fractions. To investigate Armt1 activity further, we used an alter-
native assay that detects loss of adenine absorbance resulting
from the enzyme-coupled degradation of the by-product of the
methyltransferase reaction, SAH. Initially, attempts to detect
SAH production with purified Armt1 were unsuccessful (Fig-
ure 4C). We then attempted to remove potentially inhibitory
methylation on Armt1 prior to assaying.
Compared with most other PTMs, including amine methyl-
ation, carboxyl methylation is highly unstable and spontaneously
hydrolyzes to an unmodified residue within minutes under basic
or physiologic conditions (Kim and Paik, 1976). We exploited this
lability and removed the majority of carboxyl methylation by pre-
treating Armt1 in a pH 8 solution. To prevent remethylation of the
hydrolyzed residues in Armt1, we added the cSAM-MT inhibitor
sinefungin. As a result of pretreatment, we consistently observed
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Figure 5. Armt1 Functions in the DDR
(A and B) Armt1 differentially regulates survival in SK-Br-3 (A) and MCF7 (B) cells. Cells stably expressing either control (shCon) or Armt1 targeting (shArmt1)
shRNA were exposed to DNA damage, and survival was assessed by clonogenic assay. Mean colony numbers from three replicates were normalized to the
untreated controls and are presented ± SEM.
See also Figure S4.significant levels of SAM-MT activity above background (Fig-
ure 4C). Consistent with the results generated using the vapor
diffusion assay, we detected Armt1 automethylation using this
assay, but only after pretreatment. These results support the
ability of Armt1 to negatively regulate its activity. To confirm
PCNA as a target of Armt1, we investigated SAM-MT activity af-
ter the addition of increasing amounts of recombinant PCNA
(Figure 4D). A dose-dependent increase in activity was observed
following addition of PCNA, which further supported it as a sub-
strate of Armt1. Pre-steady-state or burst kinetics were also
observed early in these assays (Figure 4E). The burst phase rep-
resents enzyme-substrate complex formation, and in the pres-
ence of Armt1 alone, the burst phase closely matched enzyme
concentration. At the end of the burst phase and when autome-
thylation of Armt1 was near complete, the reaction likely shifted
to an equilibrium between enzymemethylation and inhibition fol-
lowed by spontaneous methylation hydrolysis and enzyme reac-
tivation. A dose-dependent increase in the burst phase also was
observed upon addition of the substrate PCNA (Figure 4E). Un-
like in the presence of Armt1 alone, where all activity contributes
to inhibition of enzymatic activity, methylation of the substrate
PCNA would not contribute to enzyme inhibition, resulting in a
concentration-dependent increase in the burst phase. Thus,
based on the activities observed with the recombinant human
protein, we confirm our structural conclusions and identify the
DUF89 family member and product of the uncharacterizedCehuman gene C6orf211 gene as a cSAM-MT that methylates
both itself and PCNA.
Armt1 Regulates the DDR in Breast Cancer Cells
To explore a cellular function for Armt1, we knocked down
C6orf211 gene expression in two breast cancer cell lines with
lentiviral shRNA. SK-Br-3 and MCF7 cells stably expressing
either nontargeting control (shCon) orC6orf211 targeting shRNA
(shArmt1) were selected, and a 70% reduction in expression was
observed in SK-Br-3 cells, and an 85% reduction was observed
in MCF7 cells (Figure S4). The SK-Br-3 and MCF7 knockdown
cell lines were then assayed for clonogenic survival, and no sig-
nificant differences in damage-free survival were observed in
these cell lines after Armt1 knockdown (data not shown). How-
ever, when the knock down cell lines were exposed to different
kinds of DNA damage, Armt1 expression significantly affected
cell survival (Figure 5). Armt1 knockdown sensitized SK-Br-3
cells to UV, adriamycin (doxorubicin), and methyl methanesulfo-
nate (MMS). SK-Br-3 cells expressing alternative shRNA
constructs displayed similar phenotypes discounting off-target
effects (Figure S4C). Conversely, reduced Armt1 expression in
MCF7 cells generated the opposite phenotype (Figure 5B). In
response to UV, adriamycin, and MMS, reduced Armt1 expres-
sion produced a damage-resistant phenotype in MCF7 cells,
and similar results were observed with other shRNAs (Fig-
ure S4D). These results strongly support a role for Armt1 activity,ll Reports 10, 1288–1296, March 3, 2015 ª2015 The Authors 1293
and likely the methylation of acidic residues in PCNA, in the
cellular response to DNA damage. These results also suggest
that reduction of Armt1 activity can affect survival by sensitizing
some cell types to DNA damage while creating resistance in
others. Targeting Armt1 may therefore enhance selective killing
of tumor cells with DNA damaging cytotoxic agents.
DISCUSSION
Here, we provide the original description of Armt1, a first-in-class
eukaryotic methyltransferase encoded by the uncharacterized
geneC6orf211. Structurally, Armt1 belongs to the ‘‘DUF89’’ fam-
ily, andof the fourDUF89structures that havebeendetermined to
date, all possess conserved and strong structural similarities to
key active site residuesof theSAM-MT fold (Martin andMcMillan,
2002). Based on these structural observations, activities for the
DUF89 family of proteins have been previously proposed, but
these studies lacked biochemical and cellular analyses. For
example, in 2010, the structure of the S. cerevisiae Armt1 homo-
logwas deposited into the protein databank by a structural geno-
mics group (PDB code: 3PT1). After soaking the crystals with
6-fructophosphate, the depositors found the molecule in the
central pocket leading them to postulate it as carbohydrate
phosphatase. Instead, we observe that the yeast structure be-
longs to the SAM-MT domain family and readily docks the
cofactor SAM (data not shown), and our in-depth characteriza-
tion of carboxyl methyltransferase activity with the human homo-
log supports this domain as a SAM-MT fold. In these studies, we
not only detected methyltransferase activity in the presence of
PCNA, but also in its absence. Self-methylation of Armt1 appears
to generate negative feedback that limits its activity.
In addition to enzymatic analyses, the peer-reviewed literature
also supportsC6orf211 gene function in processes alternative to
metabolism. Mec1ATR-dependent upregulation of the C6orf211
homolog YMR027W in S. cerevisiae, for example, was observed
following MMS treatment (Gasch et al., 2001). Yeast Armt1 was
also implicated in homologous recombination repair in a study
examining spontaneous Rad52 foci formation (Alvaro et al.,
2007). In this study, knockouts of YMR027W were among a
group of knockout cells that displayed the highest rates of spon-
taneous Rad52 foci formation indicating either an increase in
DNA damage and/or reduction in DNA repair. YMR027W
knockout cells actually formed higher Rad52 foci rates than
knockouts of the homologous recombination and repair (HRR)
protein Rad51 and the RecQ helicase SGS1. Equivalent Rad52
foci formation rates were observed in knockouts of themismatch
repair gene MLH1 and the DNA repair HRR genes RAD54
andRAD57. Correspondingly, humanC6orf211 has been closely
linked to cancer. In breast cancer, C6orf211 was observed to be
tightly coexpressed with ESR1, the gene encoding the estrogen
receptor (ER) (Dunbier et al., 2011). siRNA knockdown of
C6orf211 expression reduced breast cancer cell proliferation,
which was independent of estrogen. C6orf211 gene expression
also positively correlated with proliferation metagene expression
in 354 breast tumors. In another study, a small nucleotide poly-
morphism (SNP) in close proximity to C6orf211 was identified
as a positive indicator of susceptibility to chronic myeloid leuke-
mia (Kim et al., 2011). Here we define the product ofC6orf211 as1294 Cell Reports 10, 1288–1296, March 3, 2015 ª2015 The Authorsa protein cSAM-MT that functions in the DDR. We identify that
Armt1 modifies PCNA, and we propose that methylation of this
essential DNA clamp is, at least in part, responsible for the
alterations to survival observed in Armt1 knockdown cells
following DNA damage.
The closest previously characterized functional neighbor to
Armt1 is the bacterial glutamyl cSAM-MT, CheR. By methylating
specific glutamate residues in chemotaxis receptors, CheR
modulates intracellular receptor interactions and signal trans-
duction events that cause the bacterium to swim toward nutri-
ents. Methylation of chemotaxis receptors by CheR was found
to act as gain control, allowing the bacterium to adapt receptor
output across a broad spectrum of ligand concentrations (Levit
and Stock, 2002). We have demonstrated that, in addition to
methylating the DNA replication and repair factor PCNA, Armt1
functions to regulate the DDR in human cells. Armt1 function in
the DDR also depends on cell type, and opposite survival pheno-
types were identified in SK-Br-3 and MCF7 cells. The reason for
the different survival phenotypes is currently unclear, but the
background genetics of these cell lines likely hold the keys to
these observations. One important difference between these
cells is status p53—an important mediator of the DDR in human
cells. MCF7 cells, for example, express WT p53 and can induce
expression of responsive genes in the DDR. In contrast, SK-Br-3
cells express mutant p53 that is incapable of inducing gene
expression in the DDR (Runnebaum et al., 1991). MCF7 cells
also lack the proapoptotic factor caspase 3 (Ja¨nicke et al.,
1998), which could alter survival in the DDR. Our functional
description of this uncharacterized human gene product as a
methyltransferase and its ability to differentially regulate cell
survival in the DDR also implicates Armt1 as potentially
powerful target for anticancer therapy. Future research will
help determine whether modulation of this signaling pathway
will be of clinical utility in selecting certain tumor cells to cytotoxic
therapies.
EXPERIMENTAL PROCEDURES
Cell Culture
MCF7, MDA MB468, and SKBr3 cells were obtained from ATCC and main-
tained in DMEM or McCoys 5A supplemented with 10% fetal bovine serum
(FBS) and antibiotics at 37C with 5% CO2. Cells were exposed to UV-C
(254 nm) using a Spectrolinker (Spectronics) and exposed to MMS and Adria-
mycin (Sigma) at the indicated concentrations for 4 hr. Armt1 was cloned into a
baculovirus vector used to infect T.ni insect cells (Allele Biotech) at an MOI of
1:3. T.ni cells were maintained at 27C in serum free media (Allele Biotech) and
harvested 72 hr after infection.
Assays
Vapor diffusion assays were carried out basically as described (Murray and
Clarke, 1984). Briefly, whole-cell extracts (100 mg) were incubated in the pres-
ence of 1.5 mM [3H-methyl]-SAM (PerkinElmer) and 7 mM unlableled SAM
(Sigma-Aldrich) in 50 mM Tris buffer (pH 7.5) for 1 hr at 37C. An equal volume
of a 200 mM NaOH and 2% SDS solution was added and mixed and the
mixture immediately spotted onto filter paper placed in the neck of a scintilla-
tion vial above the fluid. Vials were capped and incubated overnight at room
temperature. Volatile 3H-methanol was measured by scintillation counting
(Beckman). The SAM265 Methyltransferase Assay (GBiosciences) was per-
formed according the manufacturer’s instruction. Briefly, a loss of adenine
absorbance resulting from the degradation of SAH was monitored with a mi-
croplate reader (BioTek). Clonogenic survival and host cell reactivation assays
were performed as previously described (Koch-Paiz et al., 2004; Birger et al.,
2003) Clonogenic assays were performed by exposing the cells to DNA dam-
age followed by seeding onto 6 cm tissue culture dishes in triplicate. Cells were
fixed with 70% ethanol after 10–14 days and stained with crystal violet. Col-
onies with >30 cells were scored.
Protein Chemistry
Whole-cell extracts were generated with MPer containing protease inhibitor
cocktail (Pierce) and 1 mM DTT. Chromatography was performed using a Bio-
logicDuoFlowFPLC (BioRad).MDAMB468whole-cell extractswere subjected
to 30% NH4SO4 precipitation for 2 hr on ice. Precipitates were clarified by
centrifugation prior to passage over a 5 ml Phenyl Sepharose HP (HiTrap) col-
umn (GE Biosciences) in 20 mM phosphate buffer (pH 7.0). Active fractions
were elutedwith a linear gradient ofNH4SO4 from30 to0% in20mMphosphate
buffer (pH 7.0). Fractions were desalted with Protein Desalting Spin Columns
(Pierce) and carboxyl methyltransferase activity assayed using the vapor diffu-
sion assay in the presence of 2 mg of PCNA, as described. Active fractionswere
combined and separated on a Superdex S200 gel filtration column (GE Biosci-
ences) in 50 mM Tris, 150 mM NaCl, 10% glycerol, and 1 mM DTT (pH 7.5).
Active fractionswere acetone precipitated prior to 2DPAGE and colloidal Coo-
massie blue staining (Candiano et al., 2004). SDS-PAGE, 2D PAGE, protein
identification, and sequencing were performed as previously described (Hoelz
et al., 2006). Recombinant PCNAwas expressed as a 63His-tagged fusion us-
ing a pET303/CT-His (InVitrogen) vector or a calmodulin binding peptide (CBP)
fusion using the pDual expression system (Stratagene) and purified with Ni2+
Sepharose (GEBiosciences) or Calmodulin agarose (Stratagene), respectively.
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